Stocks: Overview

Sunday, May 19, 2013 12:30:09 AM EDT

Show Me

Novartis AG	NVS
Viacom Inc	VIA
E*TRADE Financial Corp	ETFC
Urban Outfitters Inc	URBN
KKR & Co LP	KKR
Vendum Batteries Inc	VNDB
Vanguard Large Cap ETF	VV
Yahoo! Inc	YHOO
Career Education Corp	CECO
Superior Energy Services Inc	SPN

Novartis AGNYSE:NVS Health Care : PharmaceuticalsLarge Cap BlendBased in Switzerland

$74.15

0.86 (1.15%)

Bid

Ask

B/A Size

High

74.16

Low

73.50

Volume

1,092,063 (Below Avg)

As of May 17, 2013 4:00pm ET

Prev Close

75.01

Market Cap ($)

179.5B

Today's Open

73.53

Shares Out.

2.4B

Day's Range

73.50 - 74.16

EPS (TTM)

3.91

Avg Vol (10-day)

1.3M

P/E Ratio

18.96x

Last (time)

4:00p ET 05/17/13

Ann. Dividend/Yield

$2.43/3.27%

Last (size)

16.3K

Ex-Dividend Date

02/26/13

52-Wk Range
51.20 - 75.67

Low

High

Beta

0.6

% Below High (05/23/12 - 05/15/13)

2.01%

% Held by Inst

9.35

Implied Volatility

15.5%

Short Interest (% of float as of 04/30/13)

0.08

Historical Volatility

12.8%

Historical Quotes & Splits

Current|1mo|3mo|6mo|1yr

DJIA

S&P 500

NASDAQ

SMA(50)

View Advanced Chart

May 16, 2013
2:08p	Amgen and Novartis Join Atlas Venture Fund IX As Corporate Strategic Partners (Business Wire)
6:00a	NextPharma completes executive management team with the appointment of Jean Cuine as Chief Scientific Officer (Business Wire)

May 15, 2013
5:46p	Good News for Novartis' Ilaris - Analyst Blog (Zacks.com)
2:00p	Research Team Publishes New Methods for Synthetic Generation of Influenza Vaccines (PR NewsWire)
8:00a	Array BioPharma Announces Clinical Data Presentations At The 2013 ASCO Annual Meeting (PR NewsWire)
6:30a	Tokai Pharmaceuticals Announces $35.5 Million Series E Financing (Business Wire)

May 14, 2013
4:00p	Wright Medical Group, Inc. Appoints Douglas G. Watson to Board of Directors (Business Wire)

May 13, 2013
9:57a	PDL BioPharma Misses Earnings Ests - Analyst Blog (Zacks.com)
9:20a	Earnings Beat for PETS, Margins Up - Analyst Blog (Zacks.com)

May 10, 2013
1:20a	Novartis drug Ilaris® approved by FDA to treat active systemic juvenile idiopathic arthritis, a serious form of childhood arthritis (PR NewsWire)

May 9, 2013
8:18a	Narrower than Expected Loss at Infinity - Analyst Blog (Zacks.com)

May 7, 2013
9:50a	QLT Narrows Loss - Analyst Blog (Zacks.com)

May 6, 2013
4:00p	Array Announces Global Phase 3 Trial Evaluating MEK162 In Patients With Low-Grade Serous Ovarian Cancer (PR NewsWire)
11:52a	S&P MAINTAINS HOLD OPINION ON ADSS OF NOVARTIS AG (S&P Capital IQ)
8:00a	PetMed Express, Inc. D/B/A 1-800-PetMeds Announces Its Financial Results for Fiscal 2013 (GlobeNewswire)

May 3, 2013
2:10p	Narrower-Than-Expected Loss at Incyte - Analyst Blog (Zacks.com)

May 2, 2013
7:30a	Zalicus Reports Financial Results for the First Quarter 2013 (Business Wire)
1:40a	MorphoSys Announces Clinical Milestone in Ophthalmology Program (Market Wire)

May 1, 2013
8:00a	Health Robotics Appoints Gordon Meyer to Board of Directors (PR NewsWire)

April 30, 2013
6:30a	INTERPHEX 2013: It's a Wrap on Pharma's Biggest Conference of the Year, an Industrial Info News Alert (Market Wire)

April 29, 2013
9:40a	Earnings Miss at UTHR - Analyst Blog (Zacks.com)
8:46a	ImmunoGen Narrows Loss - Analyst Blog (Zacks.com)
8:00a	Incyte Achieves $25 Million Milestone as c-MET Inhibitor INC280 Advances Into Phase II Development (Business Wire)
6:42a	Opsona Therapeutics Limited raises EUR33 million (US $ 43 million) oversubscribed Series C equity financing to advance clinical development of its lead product OPN-305 (Business Wire)

April 26, 2013
6:52p	Novartis Pharmaceuticals Corporation disputes allegations in two US Government lawsuits and looks forward to a fair discussion of the facts (PR NewsWire)
4:56p	U.S. Joins Shepherd, Finkelman, Miller & Shah, LLP Whistleblower Lawsuit Against Novartis Pharmaceuticals Corporation (Business Wire)
6:15a	Got BIO? Better Get It! BIO 2013 Report Credits Industry With 1.6 Million High-Income U.S. Jobs, an Industrial Info News Alert (Market Wire)

April 25, 2013
5:30p	Acorda Initiates Study on rHIgM22 - Analyst Blog (Zacks.com)
5:00p	FDA Designation for Merck Candidate - Analyst Blog (Zacks.com)
11:10a	InterMune Cuts Loss, Affirms View - Analyst Blog (Zacks.com)
10:51a	Novartis' Earnings, Sales Beat Estimates - Analyst Blog (Zacks.com)
9:56a	Novartis signs on to support Malaria No More's Power of One campaign to stride towards a future without malaria (PR NewsWire)
9:15a	Malaria No More Announces Innovative Partners For Its 'Power Of One' Malaria Campaign (PR NewsWire)
1:15a	Malaria No More Announces Innovative Partners For Its 'Power Of One' Malaria Campaign (PR NewsWire)

April 24, 2013
4:50p	Earnings Preview: AmerisourceBergen - Analyst Blog (Zacks.com)

Go to All Current & Historical News

Events

04/24/2013

Q1 2013 Novartis AG Earnings Release - Estimate: $1.32

02/26/2013

Novartis AG Dividend for NVS - $2.43

01/23/2013

Q4 2012 Novartis AG Earnings Release - Estimate: $1.27

10/25/2012

Q3 2012 Novartis AG Earnings Release - Estimate: $1.34

07/19/2012

Q2 2012 Novartis AG Earnings Release - Estimate: $1.38

More Calendar Events

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, AMEX, NYSE and Options. Duration of the delay for other exchanges vary.

THOMSON REUTERS

Thomson Reuters Limited.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by

Computrade Systems, Inc.,

and

S&P Capital IQ Research Disclosure /public-0:30:8

3rd Party Research Disclosure /public-0:30:8

Market Data Disclosure

Stocks: Overview

Novartis AGNYSE:NVS

May 16, 2013

May 15, 2013

May 14, 2013

May 13, 2013

May 10, 2013

May 9, 2013

May 7, 2013

May 6, 2013

May 3, 2013

May 2, 2013

May 1, 2013

April 30, 2013

April 29, 2013

April 26, 2013

April 25, 2013

April 24, 2013